Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_27997
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.
Journal
Journal of Clinical Oncology
Author(s)
Smith J.W., Walker E.B., Fox B.A., Haley D., Wisner K.P., Doran T., Fisher B., Justice L., Wood W., Vetto J., Maecker H., Dols A., Meijer S., Hu H.M., Romero P., Alvord W.G., Urba W.J.
ISSN
0732-183X (Print)
ISSN-L
0732-183X
Publication state
Published
Issued date
2003
Volume
21
Number
8
Pages
1562-1573
Language
english
Notes
Publication types: Clinical Trial ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
Publication Status: ppublish
Keywords
Adult, Aged, Aged, 80 and over, CD8-Positive T-Lymphocytes/immunology, Cancer Vaccines/administration &amp, dosage, Female, Flow Cytometry, Fluorescence, Freund's Adjuvant/administration &amp, dosage, HLA-A2 Antigen/analysis, Humans, Interferon-gamma/metabolism, Leukapheresis, Male, Melanoma/immunology, Membrane Glycoproteins/administration &amp, dosage, Membrane Glycoproteins/adverse effects, Middle Aged, Neoplasm Proteins/administration &amp, dosage, Neoplasm Proteins/adverse effects, Peptides, Pilot Projects, Skin Neoplasms/immunology, Treatment Outcome, gp100 Melanoma Antigen
OAI-PMH
oai:serval.unil.ch:BIB_27997
DOI
10.1200/JCO.2003.09.020
Pubmed
12697882
Web of science
000182300200022
Create date
19/11/2007 13:24
Last modification date
20/08/2019 14:06
Usage data